Oncology is a field in medicine which deals with the diagnosis and treatment of cancer. This branch of medicine researches identifies and takes care of cancer. The area of oncology categorizes into three different types- medical, surgical, and radiation. Medical oncology focuses on cancer treatment based on chemotherapy, targeted therapy, or immunotherapy, while surgical and radiation oncology deals with the treatment of cancer via surgical and radiation methods, respectively.
Know anyone building innovative solutions that belong in this 'Oncology'?
Providing a comprehensive program on the latest innovations in cancer treatments and research, Oncology Convention is open to all UK-based medical oncologists and their wider senior management teams. The event will focus on the four main cancers: lung, prostate, colorectal and breast. Roar B2B is a visionary events company that puts people at the centre of today’s most topical, growing and engaged industry sectors. With offices in London and Bristol, we’re dedicated to delivering sustainable sector-leading events which bring people together to build content, customer-centric community and conversation.
We are delighted to extend an invitation on behalf of the Scientific Committee to the 6th Global Meeting on Oncology and Radiology, which will be held in Madrid, Spain on November 07-08, 2022. "Insight into the advances in Radiology & Oncology" is the theme of the Radiology and Oncology 2022 conference, which includes a wide range of vitally important sessions in the fields of Oncology, Radiology, Cancer, and Imaging. All elements of cancer imaging and intervention will be covered in this interdisciplinary multi-specialty oncology course. The goal of this gathering is to provide the most up-to-date information on radiology as well as innovative cancer treatment alternatives. We will bring together academics and young scientists from all around the world.
Over the past 10 years, CHI's Immuno-Oncology Summit has become the leading annual meeting focusing on the latest applied research, providing comprehensive and in-depth coverage across all modalities and stages in the pipeline. Every year, we assemble an international mix of thought leaders and decision makers from industry and academia to bring you the latest developments in immuno-oncology, while providing access to a comprehensive 3-day program and extensive networking opportunities that CHI's IO Summit provides.
The 2022 Precision Oncology Summit: Personalizing Treatment to Improve Patient Outcomes is an oncology conference featuring leading experts in the field of precision oncology who will provide a comprehensive overview of implications of actionable molecular alterations across common malignancies. Expert faculty will discuss and analyze the latest scientific findings and practice-changing advances in precision oncology, including the key abstracts relevant to precision oncology presented at the 2022 ASCO Annual Meeting in June 2022. This conference will augment healthcare providers’ foundation of knowledge and clinical competence in several areas, including:
Integrating different platforms available for testing of actionable molecular alterations for identification of targeted therapy options.
Current and evolving paradigms in precision oncology approach for management of common malignancies.
Trends, challenges, controversies, and cost-considerations of precision oncology approaches and targeted therapies.
The NHS Oncology Conference provides a high-value and peers focused platform for NHS Oncology and Cancer specialists to share practical insights and best practices from across the UK. Our physical events offer a unique opportunity to meet with key sector stakeholders in an informal and relaxed atmosphere, this provides an ideal chance to discuss strategic change and learn from some of the most well-respected public sector professionals in the country, all while soaking up the lovely atmosphere our venues and audience provide.
The Covid pandemic caused a sharp increase in waiting times and backlogs in a healthcare system that was already operating extremely close to its maximum capacity. By September 2021, it’s estimated there were 5.83 million patients on the waiting list for elective care, 1.95 million of those patients had been waiting for more than 18 weeks, including 301,000 waiting for more than a year. To try and reduce further crisis NHS England set up a national Cancer Recovery Taskforce, headed up by Professor Peter Johnson, National Clinical Director for Cancer, and includes representatives from cancer charities, royal colleges, national teams and the NHS Cancer Programme’s Patient and Public Voices (PPV) Forum.
Oncologists across the U.S. are preparing for increased patients seeking treatment for more advanced-stage cancers than in the past. Clinicians and researchers are also redesigning the cancer patient journey and developing more sophisticated therapies that are revolutionizing what it means to treat cancer today. Join us for this virtual event and hear insights from top oncology leaders about where the field is today, and where it's headed.
After two years of a fully online event, we’re excited to be back in Liverpool with a refreshed congress. As always the event will offer three days of education and CPD with a programme that showcases the most cutting-edge content for a multidisciplinary audience that addresses the medical, scientific, educational and management issues in the diverse fields of diagnostic imaging, oncology, and radiological sciences. Alongside this is a large professional exhibition of the latest state-of-the-art equipment, services and technology available in the industry.
Join us at The NHS Oncology Conference 2022 Manchester as we explore these new areas of best practice, network with peers and share insights across a short but high-value conference. Research sources for The NHS Oncology Conference 2022 Manchester: NHS England and improvement, Cancer Research UK. At Convenzis we pride ourselves on our ability to develop, manage, and host both virtual and physical events for the public and commercial sectors. Our physical events offer a unique opportunity to meet with key sector stakeholders in an informal and relaxed atmosphere, this provides an ideal chance to discuss strategic change and learn from some of the most well-respected public sector professionals in the country, all while soaking up the lovely atmosphere our venues and audience provide.
Join more than 40,000 oncology professionals from around the world at the 2022 ASCO Annual Meeting. Stay up to date on new clinical cancer advances in every area of cancer research, gain real-time insights from world-renown faculty, and connect with one of the largest, most diverse audiences in global oncology – in person or online.
Advancing Equitable Cancer Care Through Innovation
By innovating across boundaries, we can bring down barriers to access and make care more equitable, convenient, and efficient for patients worldwide.
Due to the pandemic, the #Sachs_IOIF event will be once again hosted in a digital format. This will allow us to further support our community and past attendees, bridging Europe and the US. We will provide both the usual stimulating program and networking opportunities through our online video and audio meeting system. The programme for the 8th Annual IOIF will be spread throughout 2 days. Featuring more than 12 hours of keynotes, high-level speeches, panel discussions and spotlight showcases by leading corporates. The event brings together leaders from cancer research institutes, patient advocacy groups, early and late-stage investors, pharma’s and biotech’s.
We anticipate over 300 delegates and 20+ company presentations by established listed, private and emerging companies. Over half of these attendees are corporate and financial investors, analysts, bankers and advisors. The forum is highly transactional and based on past events we anticipate a high level of activity on the Online Meeting System, which will be open the whole week of the conference, from 23rd to 27th of May.
The joint International Congress on Innovative Approaches in Head and Neck Oncology (ICHNO) and the European Congress on Head and Neck Oncology (ECHNO) is taking place in Brussels, Belgium and Online from 3 to 5 March 2022. For those of you who might still be facing travel restrictions in advance of the conference, we are putting in place the option to participate virtually to the congress, thanks to an online platform, where sessions in digital format will be made available for both onsite and online attendees.
The European SocieTy for Radiotherapy and Oncology (ESTRO), the European Head and Neck Society (EHNS) and the European Society of Medical Oncology (ESMO) have the pleasure to invite you to participate in this congress. This joint congress promises to provide a unique platform for the dissemination of the most relevant and cutting-edge science and innovation in the field of head and neck oncology. ICHNO and ECHNO, biannual congresses respectively, promote multidisciplinarity in head and neck oncology.
The Convenzis Oncology Virtual Conference series aims to provide a secure and focused environment for NHS cancer specialists to listen, learn and engage with peers and sector leaders from across the UK and further afield.
ASCO Direct™ Highlights: 2021 Official Annual Meeting Review, an officially licensed program of the American Society of Clinical Oncology® (ASCO®) is the 9th annual conference being organized by the Binaytara Foundation and features some of the most well-known experts in the field of hematology and oncology.
Join at 7th Edition of International Conference on Clinical and Medical Oncology Conferences and webinars schedule during March 22-23, 2021 in Barcelona, Spain. Oncology 2021 brings upon a new platform to discuss and share all the advancements.
This year, we’re focused on a critical safe path forward, so you can still access groundbreaking science in oncology, the latest trends in clinical application and treatment, and insights on equitable cancer care. The 2021 ASCO Annual Meeting will be online-only – both scientific and education programs occurring June 4-8.
With members from around the world focused on learning about Tumor and Cancer immunology and its advances: this is your best opportunity to reach the largest assemblage of participants from the Tumor & Cancer immunology community. conduct presentations, distribute information’s, meet with current and potential scientists, make a splash with new drug developments, and receive name recognition at this 2-day event, world-renowned speakers, the most recent techniques, developments, and the newest updates in Tumor & Cancer immunology are hallmarks of this conference.
The current health crisis due to COVID-19 has transformed and changed how care is being delivered in Medical and Radiation Oncology areas across the US. Rapid adoption of TeleHealth by three fold, combined with Virtual Care has enabled collaborative decision-making and innovative ways to support vulnerable groups. This summit aims to:
Bring providers, commercial payors and CMS together for a one-day summit
Discuss challenges: practice changes, virtual care & impact to quality of care
Debate on the policy changes and impact across the US health system
The assurance cookie is found and is being filtered in Google Analytics.
These cookies are used to collect information about how you interact
with our website and allow us to remember you. We use this
information in order to improve and customize your browsing
experience, and for analytics and metrics about our visitors both on
this website and other media. To find out more about the cookies we
use, see our